Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q2 2023 · 10-Q
Revenue$26.84M$26.84M+124.5% vs Q2 2022 Net Income$509.00K$509.00KN/M vs Q2 2022 EPS Diluted$0.11$0.11N/M vs Q2 2022 Gross Profit$4,426,000+55.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flowderived$820,000+7.2% Margins · derivedGross margin16.5%−7.3 pt vs Q2 2022
Operating margin2.8%+38.1 pt vs Q2 2022
Net margin1.9%+37.2 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end